Gordon David F, Tucker Elizabeth A, Tundwal Kavita, Hall Heather, Wood William M, Ridgway E C
Division of Endocrinology, Department of Medicine, University of Colorado Health Sciences Center-Fitzsimons, Mail Stop 8106, P.O. Box 6511, Aurora, Colorado 80049, USA.
Mol Endocrinol. 2006 May;20(5):1073-89. doi: 10.1210/me.2005-0115. Epub 2006 Jan 5.
Mediator (MED) 220/thyroid receptor-associated protein (TRAP) 220 is a transcriptional mediator that interacts with liganded thyroid/steroid hormone receptors. MED220 haploinsufficient heterozygotes exhibited hypothyroidism and reduced TSHbeta transcripts, suggesting a specific function for TSHbeta transcription. We previously demonstrated that Pit-1 and GATA-2 can bind to a composite element within the proximal TSHbeta promoter and synergistically activate transcription. We detected MED220 expression in TtT-97 thyrotropes by Northern and Western blot analysis. Cotransfections in CV-1 cells showed that Pit-1, GATA-2, or MED220 alone did not markedly stimulate the TSHbeta promoter. However, Pit-1 plus GATA-2 resulted in an 10-fold activation, demonstrating synergistic cooperativity. Titration of MED220 resulted in a further dose-dependent stimulation up to 25-fold that was promoter specific. Glutathione-S-transferase interaction studies showed that MED220 or GATA-2 each bound the homeodomain of Pit-1, whereas MED220 interacted independently with each zinc finger of GATA-2 but not with either terminus. MED220 interacted with GATA-2 and Pit-1 over a broad region of its N terminus. These regions of interaction were also important for maximal function. Coimmunoprecipitation confirmed that all three factors can interact in thyrotropes and chromatin immunoprecipitation demonstrated in vivo occupancy on the proximal TSHbeta promoter. Thus, the TSHbeta gene is maximally activated by a combination of three thyrotrope transcription factors that act via both protein-DNA and protein-protein interactions.
中介体(MED)220/甲状腺受体相关蛋白(TRAP)220是一种转录中介体,可与配体化的甲状腺/类固醇激素受体相互作用。MED220单倍体不足的杂合子表现出甲状腺功能减退和TSHβ转录本减少,提示其在TSHβ转录中具有特定功能。我们之前证明,Pit-1和GATA-2可结合TSHβ近端启动子内的复合元件并协同激活转录。通过Northern和Western印迹分析,我们在TtT-97促甲状腺细胞中检测到MED220的表达。在CV-1细胞中共转染显示,单独的Pit-1、GATA-2或MED220均未显著刺激TSHβ启动子。然而,Pit-1加GATA-2导致激活增加10倍,显示出协同作用。MED220的滴定导致进一步的剂量依赖性刺激,最高可达25倍,且具有启动子特异性。谷胱甘肽-S-转移酶相互作用研究表明,MED220或GATA-2均可与Pit-1的同源结构域结合,而MED220可独立与GATA-2的每个锌指相互作用,但不与任何一个末端相互作用。MED220在其N末端的广泛区域与GATA-2和Pit-1相互作用。这些相互作用区域对最大功能也很重要。免疫共沉淀证实,这三种因子在促甲状腺细胞中均可相互作用,染色质免疫沉淀证明它们在体内占据TSHβ近端启动子。因此,TSHβ基因通过三种促甲状腺细胞转录因子的组合而被最大程度激活,这些因子通过蛋白质-DNA和蛋白质-蛋白质相互作用发挥作用。